HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart scans could spare cancer patients harsh chemo
Disease control CompletedThis completed Phase 3 trial tested whether using PET scans early in treatment could help personalize chemotherapy for advanced Hodgkin lymphoma. Patients were randomly assigned to either receive standard chemotherapy or have their treatment adjusted based on their PET scan resul…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New hope to tame dangerous side effect of Life-Saving transplants
Disease control CompletedThis study tested if a drug called palifermin, given before a stem cell transplant, could make the procedure safer and more effective. It involved 34 adults with blood cancers who received stem cells from an unrelated, matched donor. The main goals were to find a safe dose and se…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for lymphoma patients Who've run out of options
Disease control CompletedThis study tested whether giving the immunotherapy drug pembrolizumab every six weeks could help control two types of lymphoma that had returned or stopped responding to previous treatments. It involved 66 adults with relapsed Hodgkin's lymphoma or primary mediastinal large B-cel…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New drug offers gentler path to cancer cure, could spare patients brutal chemo
Disease control CompletedThis study tested if a newer, targeted drug called brentuximab vedotin could replace a harsh, multi-drug chemotherapy regimen (called ICE) as the first step before a stem cell transplant for patients whose Hodgkin lymphoma had returned or didn't respond to initial treatment. The …
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC